Phosphorylation of serines 287/288 in DEK regulates cell-type-specific chromatin occupancy and compaction [ATAC-seq]
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 12 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- MelanomaThis series is part of our curated briefing on it.
- Samples
- 12 samples: 6 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE326270_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1445034 and SRA study SRP687635. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 6 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9626504 HelaS3, ATAC-seq, replicate 1 HelaS3, ATAC-seq,
- GSM9626505 HelaS3, ATAC-seq, replicate 2 HelaS3, ATAC-seq,
- GSM9626506 1E7, ATAC-seq, replicate 1 1E7, ATAC-seq,
- GSM9626507 1E7, ATAC-seq, replicate 2 1E7, ATAC-seq,
- GSM9626508 SK-Mel-103,DEK siRNA, CX-4945, replicate 1 SK-Mel-103,DEK siRNA, C…
- GSM9626509 SK-Mel-103,DEK siRNA, CX-4945, replicate 2 SK-Mel-103,DEK siRNA, C…
- GSM9626510 SK-Mel-103,DEK siRNA, DMSO, replicate 1 SK-Mel-103,DEK siRNA, D…
- GSM9626511 SK-Mel-103,DEK siRNA, DMSO, replicate 2 SK-Mel-103,DEK siRNA, D…
- GSM9626512 SK-Mel-103,NC siRNA, DMSO, replicate 1 SK-Mel-103,NC siRNA, DM…
- GSM9626513 SK-Mel-103,NC siRNA, DMSO, replicate 2 SK-Mel-103,NC siRNA, DM…
- GSM9626514 SK-Mel-103,NC siRNA, CX-4945, replicate 1 SK-Mel-103,NC siRNA, CX…
- GSM9626515 SK-Mel-103,NC siRNA, CX-4945, replicate 2 SK-Mel-103,NC siRNA, CX…
- GSE142751 Genome-wide maps of chromatin state in 142 cancer cell lines [cell line] 855 samples same disease briefing · shares chromatin
- GSE317605 A Phase II Trial of Pembrolizumab plus Granulocyte Macrophage Colony Stimulating Factor in Advanced Biliary Cancer [CITE-Seq] 168 samples same disease briefing
- GSE12391 Melanoma: comparison between common nevi, radial/vertical growth phase melanoma, metastases and dysplastic nevi 114 samples same disease briefing
- GSE91061 Molecular portraits of tumor mutational and micro-environmental sculpting by immune checkpoint blockade therapy 109 samples same disease briefing
- GSE134459 Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 73 samples same disease briefing
- GSE230489 RNA-sequencing of cutaneous melanoma and non-small cell lung cancer biopsies 38 samples same disease briefing
- GSE100797 Mutational and neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma 25 samples same disease briefing
- GSE123728 Clinical and Immunologic Activity of a Single Dose of Neoadjuvant PD-1 Blockade and Predictors of Clinical Outcomes in Resectable Melanoma 24 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.